Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Termino C 10712 AB
AB
Dissolved
Org 5568585706
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2011 · 15 years old
7 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Termino C 10712 AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
27M
21M
14M
7M
0M
2018: 7M
7M
2018
2019: 6M (-14% vs 2018)
6M
-14%
2019
2020: 14M (+133% vs 2019)
14M
+133%
2020
2021: 22M (+57% vs 2020)
22M
+57%
2021
2022: 6M (-73% vs 2021)
6M
-73%
2022
EBITDA
SEK millions
7M
4M
2M
0M
-3M
2018: 0M
0M
2018
2019: 0M
0M
2019
2020: 1M
1M
2020
2021: 5M (+400% vs 2020)
5M
+400%
2021
2022: -1M (-120% vs 2021)
-1M
-120%
2022
Income statement
SEK thousands
Item
2022
2021
2020
2019
2018
Revenue
5 875
21 987
14 140
6 188
7 018
Staff expenses
—
—
—
—
—
EBITDA
−1 144
5 134
1 077
−117
469
Depreciation & amort.
−115
−60
−15
−8
−8
EBIT
−1 259
5 074
1 062
−125
461
Net financials
1
−5
−61
89
−302
Profit before tax
298
3 790
725
22
102
Tax
−74
−794
−178
−18
−39
Net profit
224
2 996
547
4
63
Balance sheet
SEK thousands
Item
2022
2021
2020
2019
2018
Total assets
3 512
8 041
3 315
2 914
3 185
Equity
1 679
3 051
1 035
488
483
Long-term debt
0
0
0
466
618
Short-term debt
1 833
3 434
2 005
1 961
2 026
Total debt
1 833
3 434
2 005
2 427
2 644
Financial ratios
5-year trend
EBITDA margin
−19,5 %
This company
15,8 %
Market median
This company
Market median
223% below market
2018
2022
Equity ratio
47,8 %
This company
38,2 %
Market median
This company
Market median
25% above market
2018
2022
Return on equity
13,3 %
This company
18,4 %
Market median
This company
Market median
28% below market
2018
2022
Net profit margin
3,8 %
This company
8,1 %
Market median
This company
Market median
53% below market
2018
2022
Asset turnover
1,67×
This company
1,12×
Market median
This company
Market median
49% above market
2018
2022
Debt / equity
1,09×
This company
0,62×
Market median
This company
Market median
76% above market
2018
2022
Annual reports & filings
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
View
PDF
More on Termino C 10712 AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
